Hexarelin Half-Life and Stability: What Research Shows
Research Notice: This article covers research on Hexarelin research peptide and Ipamorelin research peptide — available from Palmetto Peptides for laboratory use only.
The Short Answer
Based on pharmacokinetic data from preclinical research, hexarelin has a relatively short plasma half-life — estimated at approximately 30 to 60 minutes in most animal models. This short biological window reflects rapid enzymatic degradation in plasma and contributes to the transient nature of the GH pulse it produces. In terms of physical peptide stability, lyophilized hexarelin stored at proper temperatures can remain intact for extended periods, while reconstituted solutions require careful cold-chain management to preserve activity.
For a complete overview of this research area, see the Complete Guide to Hexarelin Research Peptide from Palmetto Peptides.
For background on this topic, see the Complete Guide to Hexarelin Research Peptide from Palmetto Peptides.
What Is Half-Life and Why Does It Matter in Peptide Research?
Half-life is the time it takes for the concentration of a compound in a biological system to decrease by 50%. For peptides like hexarelin, this is primarily determined by:
In practical research terms, half-life affects:
- How quickly the biological response appears and fades
- How often a compound needs to be administered in multi-dose protocols
- The timing of sample collection to capture peak vs. trough measurements
- The relationship between dose administration time and measurable outcomes
Hexarelin Half-Life: Pharmacokinetic Data Summary
Hexarelin's pharmacokinetics have been characterized in rodent models and in early human pharmacokinetic studies (the latter now largely of historical research interest). The following summarizes key findings:
| Parameter | Observed Range | Study Condition |
|---|---|---|
| Plasma half-life | ~30–60 minutes | Rodent IV/SC administration |
| Time to peak GH (Tmax) | 15–30 minutes post-injection | SC administration, rodent |
| GH response duration | 60–90 minutes post-peak | Returns to baseline |
| Volume of distribution | Moderate (tissue penetration noted) | Rodent pharmacokinetic studies |
| Primary clearance route | Enzymatic (plasma peptidases) + renal | Inferred from analog studies |
The short half-life is characteristic of synthetic GHRPs in general. Because hexarelin is a small peptide, it lacks the protective modifications (such as PEGylation or albumin-binding sequences) used in longer-acting pharmaceutical compounds. Once in circulation, it is subject to rapid cleavage by dipeptidyl peptidase IV (DPP-IV) and other plasma enzymes.
What the Short Half-Life Means for Research Protocol Design
Understanding hexarelin's half-life is directly relevant to how researchers structure their study timelines and sample collection protocols.
GH Pulse Measurement Windows
Because the GH response to hexarelin peaks at approximately 15–30 minutes post-injection and returns to baseline within 90–120 minutes in most animal models, timed blood sampling is essential. Studies that miss this window — collecting samples too early or too late — will underestimate or miss the GH response entirely.
Standard practice in preclinical hexarelin studies is to collect samples at:
- Baseline (pre-injection)
- 15 minutes post-injection
- 30 minutes post-injection
- 60 minutes post-injection
- 90–120 minutes post-injection
This 5-point minimum allows researchers to characterize peak GH, area under the curve (AUC), and return-to-baseline timing.
Dosing Frequency in Multi-Day Studies
The short half-life means hexarelin is cleared rapidly between doses, which contributes to the discrete, pulsatile nature of GH stimulation in research models. However, as covered in the dosage article, receptor desensitization is a separate phenomenon from half-life — the peptide may clear quickly, but the receptor can still become desensitized with repeated stimulation.
These two dynamics — short pharmacokinetic half-life and receptor desensitization — interact in ways that require careful protocol design in multi-day studies.
Peptide Stability: Lyophilized vs. Reconstituted
Hexarelin's research utility depends not only on its biological half-life in vivo but also on its stability as a stored compound in the laboratory. These are distinct concepts that are worth separating clearly.
Lyophilized (Freeze-Dried) Hexarelin
In lyophilized form, hexarelin is considerably more stable than in solution. Properly stored lyophilized peptide — sealed, protected from light and moisture, and held at appropriate cold-storage temperatures — can retain structural integrity for an extended period, commonly cited as 12–24 months in standard peptide stability literature.
Key storage factors for lyophilized hexarelin:
- Temperature: Refrigerated storage (2–8°C) recommended; freezing at -20°C extends shelf life further
- Humidity: Desiccant and sealed vials essential; moisture is a primary degradation driver
- Light: UV exposure degrades peptide bonds; amber or opaque vials recommended
Reconstituted (In-Solution) Hexarelin
Once reconstituted in bacteriostatic water or sterile saline, hexarelin's stability window shortens considerably. Most research guidance and manufacturer documentation suggests reconstituted solutions should be:
- Kept refrigerated at 2–8°C
- Used within 30 days for optimal activity
- Frozen at -80°C for extended storage if aliquoted into single-use fractions
- Never subjected to freeze-thaw cycling, which accelerates structural degradation
Stability Threats to Be Aware Of
| Degradation Factor | Effect on Hexarelin | Mitigation |
|---|---|---|
| Oxidation | Tryptophan residue oxidation, loss of potency | Store under inert gas, minimize air exposure |
| Hydrolysis | Peptide bond cleavage in solution | Use BAC water, minimize time in solution |
| Heat | Accelerates all degradation pathways | Cold chain at all handling stages |
| UV light | Photo-oxidation of aromatic residues | Amber vials, minimize light exposure |
| Freeze-thaw cycling | Aggregation, precipitation, loss of solubility | Aliquot before freezing |
Comparing Hexarelin Half-Life to Related Research Peptides
| Peptide | Approximate Plasma Half-Life | Notes |
|---|---|---|
| Hexarelin | ~30–60 minutes | Short; rapid enzymatic clearance |
| Ipamorelin | ~2 hours | Slightly longer than hexarelin |
| GHRP-6 | ~15–30 minutes | Among shortest in GHRP family |
| CJC-1295 (no DAC) | ~30 minutes | Short; often paired with GHRP for this reason |
| CJC-1295 (with DAC) | ~6–8 days | Drug Affinity Complex extends half-life dramatically |
| Tesamorelin | ~26 minutes | Very short; synthetic GHRH analog |
The short half-life of hexarelin is one reason research protocols often focus on acute GH response measurements rather than sustained-elevation paradigms.
Frequently Asked Questions
Q: What is the half-life of hexarelin?
A: Based on preclinical pharmacokinetic data, hexarelin has an estimated plasma half-life of approximately 30 to 60 minutes in animal models, with the GH response peaking at 15–30 minutes post-administration and returning to baseline within 90–120 minutes.
Q: How long does reconstituted hexarelin remain stable?
A: Reconstituted hexarelin in bacteriostatic water stored at 2–8°C is generally considered stable for approximately 30 days under optimal laboratory conditions. Frozen aliquots at -80°C extend this significantly.
Q: Does hexarelin have a longer or shorter half-life than ipamorelin?
A: Hexarelin has a shorter plasma half-life than ipamorelin in most preclinical models (approximately 30–60 minutes vs. approximately 2 hours for ipamorelin).
Q: How should lyophilized hexarelin be stored to preserve stability?
A: In sealed, desiccated vials at 2–8°C or frozen at -20°C to -80°C, protected from light and moisture. See our full storage guidelines article for detailed recommendations.
Q: Is hexarelin approved for human use?
A: No. Hexarelin is not approved by the FDA or any regulatory agency for human or veterinary use and is sold exclusively as a research compound for licensed laboratory use.
Related Articles
- The Complete Research Guide to Hexarelin (Pillar Page)
- Best Practices for Storing Hexarelin in Research Environments
- What Is Hexarelin? Mechanism of Action in Research Models Explained
- Hexarelin Dosage in Research Settings: Common Protocol Structures
- How Hexarelin Interacts with the Ghrelin Receptor (GHS-R1a)
- Hexarelin and IGF-1 Response: What Preclinical Research Suggests
Explore Hexarelin and Related Peptides
- Hexarelin — Palmetto Peptides Research Catalog
- Ipamorelin — Research Peptide
- CJC-1295 — Research Peptide
Selected Peer-Reviewed References
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Article",
"headline": "Hexarelin Half-Life and Stability: What Research Shows",
"description": "A review of hexarelin's pharmacokinetic profile, plasma half-life, and peptide stability data from preclinical research — including what it means for laboratory storage and study design.",
"author": {
"@type": "Organization",
"name": "Palmetto Peptides Research Team"
},
"publisher": {
Researchers seeking a broader review can consult the Complete Guide to Hexarelin Research Peptide, which covers the full research landscape in detail.
Researchers looking for a broader overview of this compound can refer to the Complete Guide to Hexarelin Research Peptide, which covers the full research landscape in detail.
"@type": "Organization",
"name": "Palmetto Peptides"
},
"dateModified": "2025",
"inLanguage": "en-US"
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "What is the half-life of hexarelin?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Based on preclinical pharmacokinetic data, hexarelin has an estimated plasma half-life of approximately 30 to 60 minutes in animal models, with the GH response peaking at 15–30 minutes post-administration and returning to baseline within 90–120 minutes."
}
},
{
"@type": "Question",
"name": "How long does reconstituted hexarelin remain stable?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Reconstituted hexarelin in bacteriostatic water stored at 2–8°C is generally considered stable for approximately 30 days under optimal laboratory conditions. Frozen aliquots at -80°C extend this significantly."
}
},
{
"@type": "Question",
"name": "Is hexarelin approved for human use?",
"acceptedAnswer": {
"@type": "Answer",
"text": "No. Hexarelin is not approved by the FDA or any regulatory agency for human or veterinary use and is sold exclusively as a research compound for licensed laboratory use."
}
}
]
}
]
}
Palmetto Peptides Research Team
For educational and informational purposes only. Hexarelin is not approved for human or veterinary use and is intended solely for licensed research environments.
Related research: hexarelin mechanism of action, and hexarelin preclinical research findings.
See Also: Complete Hexarelin Research Guide — Mechanism, Studies, and Lab Applications